74 results
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
, and on April 26, 2024, we effected a 75-for-1 reverse split of our Common Stock.
Common Stock
Voting Rights
Holders of our Common Stock are entitled to one … vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. An election of directors by our
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
, every 75 shares of the Company’s pre-reverse split common stock was combined and reclassified as one share of common stock. Proportionate voting rights … submitted to a vote of stockholders and do not have cumulative voting rights. An election of directors by our stockholders shall be determined
8-K
EX-4.3
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
as Stockholder until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
8-K
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
or privileges of a holder of Common Stock, including any voting rights, until such holder exercises such holder’s New Warrants or such PA Warrant
8-K
EX-4.2
z0rp6h 2cto
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
EX-4.1
phcqec
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
p2wc5cn
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
424B3
1nso obgu
2 Feb 24
Prospectus supplement
12:00am
DEF 14C
kvp5n6c2u1g zdm
29 Jan 24
Information statement
8:00am
PRE 14C
b668s2l7lq66n65g
17 Jan 24
Preliminary information
5:05pm
8-K
EX-4.1
p5ncad oyd8kjr
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
f0iaqv
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.2
gmdbi6ze38sl06m
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.2
vn3gdsezi7oqf 21
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
0xs3f35udspl4mb1
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.3
7g6l0rh8md1t wrz0k
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm